Specific loss of GIPR signaling in GABAergic neurons enhances GLP-1R agonist-induced body weight loss
Objectives: Dual incretin agonists are among the most effective pharmaceutical treatments for obesity and type 2 diabetes to date. Such therapeutics can target two receptors, such as the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor in t...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2025-05-01
|
| coleção: | Molecular Metabolism |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2212877824002059 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|